Cytoguide ApS's Other Investors

Cytoguide ApS raised a round of funding on , . Investors include Novo A/S.

CytoGuide focuses on the development of two-component drugs that has the potential to maximise the effectiveness of a well-known Rheumatoid Arthritis treatment while drastically minimising its side ef…

Articles about Cytoguide ApS's Other Investors: